The group's principal activity is to provide pharmacological research solution. The group provides pharmacodynamic and pharmacokinetic studies, determination of time action profiles, in-house extended stay studies, proof-of-concept / first-in-man / bioequivalence studies / drug interaction studies / bridging studies / metabolic pathways / stable tracers / tissue biopsies and cardiovascular studies. The group operates from the United States.
